Insulin Syringes Recalled

Insulin syringes sold at WalMart and Sam’s Club have been recalled by the FDA. The manufacturer of the syringes, Covidien Ltd. is recalling 471,000 ReliOn disposable syringes because of a mislabeling error that could cause patients to receive 2.5 times the intended dosage.
According to the FDA, “the recall applies to the following lot number and product information:
— Lot Number 813900
— ReliOn 1cc, 31-gauge, 100 units for use with U-100 insulin
Only ReliOn syringes from this lot number and labeled as 100 units for use with U-100 insulin are the subject of the recall.”
During the packaging process for this lot, some syringes labeled for use with U-40 insulin were mixed with syringes labeled for use with U-100 insulin, then all packaged individually and in boxes as 100 units for use with U-100 insulin.
The manufacturer has distributed 4,710 boxes in the recalled lot, which equals 471,000 individual syringes. Wal-Mart sold the syringes at Wal-Mart stores and Sam’s Clubs from Aug. 1, 2008, until Oct. 8, 2008.